ArticlebioRxiv : the preprint server for biology2026
Device-embedded accelerometry complements neural signals for tracking parkinsonian motor states.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Adaptive deep brain stimulation (aDBS) relies on physiological biomarkers to infer motor state and guide therapeutic stimulation in Parkinson's disease. However, neural biomarkers may themselves be altered by stimulation, potentially limiting their utility for closed-loop control. We address this limitation by testing whether DBS device-embedded accelerometers can accurately track Parkinsonian motor state across stimulation conditions. We analysed over 1,900 hours of chronic recordings of subthalamic nucleus (STN), sensorimotor cortical and device-embedded accelerometry signals acquired before and during continuous STN stimulation, alongside continuous wearable assessments of bradykinesia and dyskinesia. Across stimulation conditions, accelerometry-derived features robustly tracked motor symptom severity and outperformed neural features for symptom decoding. Mechanistically, total STN beta power - a widely used biomarker for aDBS - proved less informative because it conflates periodic and aperiodic neural processes with opposing relationships to motor state. Under active stimulation, periodic beta activity showed reduced coupling to symptom severity, whereas STN aperiodic activity, cortical periodic activity and cortico-subthalamic coherence remained comparatively stable. Together, these findings demonstrate that neural and behavioural biomarkers exhibit differential robustness during deep brain stimulation and identify device-embedded accelerometry as a robust behavioural biomarker of motor state, motivating its use in next-generation adaptive DBS systems.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.